Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | KDM5A | P29375 | 3/20 | 0.50 |
| ▸ | PHF8 | Q9UPP1 | 3/20 | 0.50 |
| ▸ | KDM2A | Q9Y2K7 | 3/20 | 0.50 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | KDM4A | O75164 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.43 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9742678 | 0.97 | HPGD (0.55) | HPGDKDM5APHF8KDM2AKDM4C | |
| SCHEMBL11024174 | 0.97 | HPGD (0.55) | HPGDKDM5APHF8KDM2AKDM4C | |
| SCHEMBL15263859 | 0.97 | HPGD (0.50) | HPGDKDM5APHF8KDM2AKDM4C | |
| SCHEMBL9130865 | 0.97 | HPGD (0.55) | HPGDKDM5APHF8KDM2AKDM4C | |
| Cyclohexane Propionic Acid SCHEMBL18344239 | 0.97 | HPGD (0.55) | HPGDKDM5APHF8KDM2AKDM4C | |
| Hydrochloric Acid SCHEMBL785098 | 0.97 | HPGD (0.50) | HPGDKDM5APHF8KDM2AKDM4C | |
| SCHEMBL587548 | 0.97 | HPGD (0.50) | HPGDKDM5APHF8KDM2AKDM4C | |
| Cyclohexane Propionic Acid SCHEMBL391087 | 0.97 | HPGD (0.55) | HPGDKDM5APHF8KDM2AKDM4C | |
| SCHEMBL1595661 | 0.97 | HPGD (0.55) | HPGDKDM5APHF8KDM2AKDM4C | |
| SCHEMBL31323847 | 0.97 | HPGD (0.55) | HPGDKDM5APHF8KDM2AKDM4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 65623 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12590065-B2 | Levorphanol prodrugs and processes for making and using them | ZEVRA THERAPEUTICS, INC. (US) | 2026-03-31 | — | — | US | claimed |
| US-12588693-B2 | Composition for producing hydrogen rich water and other products | H2 WATER TECHNOLOGIES LTD. (CA) | 2026-03-31 | — | — | US | claimed |
| EP-4161557-B1 | WS-635 FOR USE IN THE TREATMENT OR PREVENTION OF SARS-COV-2 INFECTION | WATERSTONE PHARMACEUTICALS WUHAN CO LTD (CN) | 2026-03-11 | — | — | EP | claimed |
| WO-2026044024-A1 | COMPOSITIONS COMPRISING COMBINATIONS OF PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF AMYLIN ANALOG, AND USES THEREOF | I2O THERAPEUTICS, INC. (US) | 2026-02-26 | — | — | WO | claimed |
| US-12551465-B2 | Pharmaceutical composition for treatment of hypertrophic cardiomyopathy and treatment method using same composition | CELLTRION INC. (KR) | 2026-02-17 | — | — | US | claimed |
| EP-4480953-B1 | TYK2 INHIBITORS AND USES THEREOF | ALUMIS INC (US) | 2026-02-04 | — | — | EP | claimed |
| EP-4461734-B1 | TYK2 INHIBITORS AND USES THEREOF | ALUMIS INC (US) | 2026-02-04 | — | — | EP | claimed |
| US-12527804-B2 | Microemulsion delivery systems for alcohol-soluble species including DHEA, pregnenolone, and chrysin for reducing menopausal symptoms | Quicksilver Scientific, Inc. (US) | 2026-01-20 | — | — | US | claimed |
| US-20260014144-A1 | USE OF OVATODIOLIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF IN PREVENTION AND TREATMENT OF RENAL FIBROSIS | ZHUJIANG HOSPITAL SOUTHERN MEDICAL UNIV (CN) | 2026-01-15 | — | — | US | claimed |
| US-12508258-B2 | Quinoline derivative for treating rheumatoid arthritis | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) | 2025-12-30 | — | — | US | claimed |
| US-5144037-A | Viricides | G. D. SEARLE & CO. (US) | 1992-09-01 | — | — | US | claimed |
| EP-0307135-B1 | 17-SUBSTITUTED ANDROSTA-1,4-DIEN-3-ONE DERIVATIVES | FARMITALIA CARLO ERBA S.r.l. (IT) | 1992-08-19 | — | — | EP | claimed |
| EP-0494850-A2 | Novel antiviral compounds | G.D. Searle & Co. (US) | 1992-07-15 | — | — | EP | claimed |
| EP-0412848-A2 | Quinoline derivatives, process for their preparation and their use as medicaments | ZENECA LIMITED (GB) | 1991-02-13 | — | — | EP | claimed |
| US-4886785-A | VIRICIDES, HERPES SIMPLEX | HOFFMANN-LA ROCHE INC. (US) | 1989-12-12 | — | — | US | claimed |
| US-4882316-A | CONTROL AND PREVENTION OF VIRAL INFECTIONS | HOFFMANN-LA ROCHE INC. (US) | 1989-11-21 | — | — | US | claimed |
| US-4272630-A | CARBOXYLATES, ANTIINFLAMMATORY | ALIG L | 1981-06-09 | — | — | US | claimed |
| US-4256745-A | OXYTOCICS; DURABILITY | SCHERING AKTIENGESELLSCHAFT (DE) | 1981-03-17 | — | — | US | claimed |
| US-4196204-A | ANTIANDROGENS, ACNE, SEBORRHEA | SCHERING AKTIENGESELLSCHAFT (DE) | 1980-04-01 | — | — | US | claimed |
| US-3933903-A | Process for the preparation of cycloalkylalkane carboxylic acid | AKZO N.V. (NL) | 1976-01-20 | — | — | US | claimed |